Clinical Trials
2 trialsNCT03414229 2026-04-23
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04463771 2025-12-10
POD1UM-204
Incyte Corporation
Phase 2 Active not recruiting